Clifford Bechtold
Compliance Officer bij BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Actieve functies van Clifford Bechtold
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Compliance Officer | - | - |
| Chief Operating Officer | 25-10-2017 | - | |
| BIOHAVEN LTD. | Compliance Officer | - | - |
Loopbaan van Clifford Bechtold
Eerdere bekende functies van Clifford Bechtold
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-10-2011 | 01-11-2013 |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 01-04-2009 | 01-10-2011 |
Opleiding van Clifford Bechtold
| South Dakota State University | Undergraduate Degree |
| The Creighton University School of Medicine | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| 2 | |
| 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Compliance Officer | 2 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| BIOHAVEN LTD. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Health Technology |
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
- Beurs
- Insiders
- Clifford Bechtold
- Ervaring
